Priya Abraham

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152

The paper evaluates the neutralizing activity of sera from vaccinated and recovered individuals against SARS-CoV-2 Delta, Delta AY.1, and B.1.617.3 variants, finding reduced but still effective neutralization.

Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India

The paper analyzes spike protein mutations in SARS-CoV-2 variants from Maharashtra, India, identifying lineage B.1.617 with mutations linked to increased transmissibility and reduced antibody neutralization.

Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum

Sera from 26 BBV152/COVAXIN recipients neutralised the UK variant about as well as a heterologous strain in plaque reduction tests, arguing against escape from vaccine-induced antibodies.